Stoke Therapeutics (STOK) Non-cash Items (2018 - 2025)

Stoke Therapeutics' Non-cash Items history runs 8 years deep, the most recent figure standing at $5.1 million for Q4 2025.

• In Q4 2025, Non-cash Items fell 74.96% year-over-year to $5.1 million; the TTM figure through Dec 2025 stood at $5.1 million (down 74.96% YoY), while the FY2025 annual figure was $5.1 million, down 74.96% from the prior year.
• Non-cash Items was $5.1 million for Q4 2025 at Stoke Therapeutics, down from $20.4 million in the prior quarter.
• In the past five years, Non-cash Items ranged from a high of $65.0 million in Q4 2021 to a low of $5.1 million in Q4 2025.
• Historically, Non-cash Items has averaged $23.9 million across 5 years, with a median of $20.4 million in 2024.
• The sharpest annual moves came in 2024 and 2025: Non-cash Items jumped 142.12% in 2024, then tumbled 74.96% in 2025.
• A 5-year view of Non-cash Items shows it stood at $65.0 million in 2021, then plunged by 68.3% to $20.6 million in 2022, then plunged by 59.05% to $8.4 million in 2023, then soared by 142.12% to $20.4 million in 2024, then sank by 74.96% to $5.1 million in 2025.
• The last three Non-cash Items figures came in at $5.1 million (Q4 2025), $20.4 million (Q4 2024), and $8.4 million (Q4 2023), per Business Quant data.